Qualigen Therapeutics stock soars after Faraday Future announces $30M investment
PositiveFinancial Markets

Qualigen Therapeutics saw a significant boost in its stock price following the announcement of a $30 million investment from Faraday Future. This investment not only reflects confidence in Qualigen's potential but also highlights the growing interest in innovative biotech companies. Such financial backing can lead to increased research and development opportunities, ultimately benefiting the healthcare sector and investors alike.
— Curated by the World Pulse Now AI Editorial System